1. Stocks
  2. Amicus Therapeutics Inc
  3. Swot
swot-logo

Amicus Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Amicus Therapeutics Inc has 14 Strengths, 10 Weaknesses, 0 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Turnaround Companies: Loss to Profit QoQ

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Increasing Revenue every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Annual Net Profits improving for last 2 years

Increasing profits every quarter for the past 3 quarters

Stock with Low PE (PE < = 10)

Volume Shockers

Companies with High Debt

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Top Losers

Near 52 Week Low

Declining Net Cash Flow : Companies not able to generate net cash

Weak Momentum: Price below Short, Medium and Long Term Averages

Near 52 Week Low

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Promoters increasing shareholding QoQ

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks